Quinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Year: 2025
Type: review
Abstract: BACKGROUND: Quinoline-derived metabolites exhibit notable chemical complexity. What causes minor structural alterations to induce significant changes in disease outcomes? Historically, eclipsed by more straightforward scaffolds, these chemicals serve as a dynamic hub in tryptophan metabolism, linking immunomodulation, excitotoxicity, and cancer. However, many of these compounds struggle to cross the blood-brain barrier, and we still do not fully understand how certain structural changes affect their bioavailability or off-target effects. Thus, contemporary research highlights halogenation, esterification, and computational modeling to enhance structure-activity relationships. SUMMARY: This narrative review emphasizes the integration of rational drug design, multi-target ligands, and prodrug methods in enhancing quinoline scaffolds. We explore each molecule's therapeutic promise, refine each scaffold's design, and develop each derivative to maximize clinical utility. Translating these laboratory findings into clinical practice, however, remains a formidable challenge. CONCLUSIONS: Through the synthesis of findings regarding NMDA receptor antagonism, improved oral bioavailability, and reduced metabolic instability, we demonstrate how single-site changes might modulate excitotoxicity and immunological signaling. Advancing quinoline-based medicines will yield significant advancements in neurology, psychiatry, and oncology. This enlarged framework fosters collaborative discovery, engages various audiences, and advances the field towards next-generation disease-modifying therapies. Robust preclinical validation, patient classification, and comprehensive toxicity evaluations are crucial stages for achieving these extensive endeavors and fostering future therapeutic discoveries globally.
Source: Pharmaceuticals
DOI: 10.3390/ph18050607
Authors: Masaru Tanaka, István Szatmári, László Vécsei
Institutions: University of Szeged, Hungarian Research Network
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Keywords: kynurenic acid, quinoline derivatives, tryptophan metabolism, NMDA receptor antagonism, excitotoxicity, immunomodulation, blood-brain barrier, oral bioavailability, halogenation, esterification, structure-activity relationship, prodrugs, multi-target-directed ligands, neurodegenerative diseases, mental illness, cancer therapy
Open Access status: gold
Estimated APC paid: $3,499
Awards: G2326201979, G5823049995, G6589236725
OpenAlex ID: W4409668526
